This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Contrast Media Injectors Market

Market Insights on Contrast Media Injectors covering sales outlook, demand forecast & up-to-date key trends

Contrast Media Injectors Market by Product (CT Injectors, MRI Injectors, and Cardio Injectors), by End User (Hospitals, Ambulatory Surgical Centres, and Diagnostics Centres) & Region - Forecast 2022-2030

Contrast Media Injectors Market Snapshot

[269 pages Report] The global contrast media injectors market was valued at US$ 1.4 Bn in 2021 and is expected to reach US$ 2.4 Bn by 2030, finds Future Market Insights (FMI) in a recent market survey.

Data Points

Market Insights

Market Value 2021

USD 1.4 Bn

Market Value 2022

USD 1.5 Bn

Market Value 2030

USD 2.4 Bn

CAGR 2022-2030

6.2%

Key Players

The key players are Bayer AG, Nemoto Kyorindo Co. Ltd., Mallinckrodt, Bracco Imaging, Ulrich GmBh, Guerbet SA, Medtron AG,

Share of Top 5 Countries           

58.1%

Growing prevalence of trauma cases, rising number of radiology procedures using contrast media, increase in geriatric population and growth of diagnostic imaging centers are primary factors boosting growth of the contrast media injectors market.

Moreover, use of contrast media in radiology to enhance image quality for diagnosis of tumor is projected to develop significantly in the estimate period owing to increasing prevalence of cancer worldwide. All these factors are expected to drive the market growth further.

Contrast media injectors market holds nearly 4.2% market value share of the US$ 36.1 Bn diagnostic imaging market in 2021. In addition, increasing awareness among physicians regarding patient safety during contrast media insertion is forcing market players to upgrade safety parameters in contrast media injectors.

Strengthening of supply chain, particularly in regions such as Asia Pacific and Middle East and Africa, are the key focus areas for players in this market. There is an increasing necessity to efficiently meet needs of various healthcare facilities, while ensuring supply of the best contrast media products, as quality is of utmost importance to end users.

Governments are providing ample funding for diagnostic imaging services, with funding increasing substantially each year owing to increasing applications of diagnostic imaging in the field of radiology and image-guided minimally invasive surgery.

Customize this Report

Let us know your requirement to get
100% FREE customization

How The Market Progressed Till June 2022?

Particulars

Details

H1 – 2021

5.86%

H1 – 2022 Projected

6.22%

H1 – 2022 Outlook

6.12%

BPS Change - H1, 2022 (O) – H1, 2022 (P)

(-) 10 ↓

BPS Change– H1, 2022 (O) – H1, 2021

(+) 26 ↑

The variation between the BPS values observed within this market in H1, 2022 - Outlook over H1, 2022 Projected reflects a decline of 10 BPS units. According to an FMI analysis, the market for contrast media injectors would grow by 26 basis share points (BPS) in H1-2022(O) as compared to H1-2021.

The rising BPS value for the contrast media injectors market can be ascribed to the growing demand for minimally invasive procedures, as well as the significant increase in financing and grants necessary to improve existing product lines.

The global contrast media injectors market is influenced by quality and safety regulations and licensure. Macroeconomic, regulatory, and industrial variables, all have an impact on the market.

The Imaging Bulk Package (IBP), a multi-patient, multi-dose compliant contrast medium approved by the FDA for POC usage in the CT suite was created to improve safety and workflow while reducing risk and preserving compliance with multi-dose CT contrast media, and is a key market development factor.

Other market segments, on the other hand, are expected to perform objectively and achieve lucrative growth prospects in the second half of the forecast period, especially with the development of CT and MRI contrasting agents.

2014-2021 Contrast Media Injectors Market Demand Outlook Compared to 2022-2030 forecast

Sales of contrast media injectors grew at a CAGR of 5.4% between 2014 and 2021.

The primary factors boosting the contrast media injector’s market growth are rising number of radiology procedures using contrast media and focus on reducing human error and increasing patient safety.

Contrast media is used to improve the diagnostic value to get imaging clearance. It helps distinguish selected areas of the body from surrounding tissue. It is for ease of physicians to diagnose disease by improving the visibility. So, healthcare professionals make it compulsory to undergo radiological testing with contrast media to come on any closing statement for particular disease.

Most of the hospitals and ambulatory surgical centers do the radiological procedures using contrast media for patients with chronic disease, accident, autoimmune diseases. All these patients mostly prefer to go to hospitals for testing in order to get proper diagnosis of disease. So this radiology procedures with contrast media give boost to the market.

Contrast Media Injectors Market Download Report Brochure

Currently few contrast media injectors are available in the market that can be connected to the hospital’s IT system through which the system can directly access data from the hospital information systems (HIS) or electronic medical record (EMR) systems to adjust the dose, thus reducing human error. This creates opportunities for leading players to come up with innovative idea and bloom the market.

Considering this, FMI expects the global contrast media injectors market to grow at a CAGR of 6.2% through 2030.

Which Factors Are Restraining Demand for Contrast Media Injectors ?

Air emboli formation, which arises from a major air infusion that generates an air lock in the pulmonary artery, causes blood pressure to drop quickly, followed by cardiovascular collapse, is a major problem encountered during contrast media injection.

Air emboli formed during contrast media injection can restrict right ventricular outflow or clog pulmonary arterioles, resulting in significant complications such as cardiovascular collapse. The worldwide revenue growth of the contrast media injectors market is projected to be hampered by adverse consequences associated with contrast media injection.

End-user demand for technologically improved contrast media injectors, such as IT-enabled contrast media injectors that can connect to a hospital database for dosage monitoring, is driving up contrast media injector prices.

The rising cost of contrast media injectors is likely to restrict market growth throughout the forecast period, as most small and medium-sized hospitals are unable to purchase them. The demand from end users for creative advancements in contrast media injectors has resulted in a significant increase in the price of CT and MRI injectors, which is limiting the sale of these products to facilities without ample funding.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What is the Impact of the COVID-19 Crisis on the Contrast Media Injectors Market?

The COVID-19 epidemic had a terrible worldwide impact on population health as well as a significant economic impact on the majority of countries. The pandemic has put enormous strain on the world's healthcare systems. To prevent the spread of illness and save health care resources for COVID-19 patients, health care institutions and providers had been told to halt performing elective surgical operations and medical evaluations during this time.

The amount of imaging cases in many radiology departments has dropped dramatically. However, in very severe cases of COVID-19, contrast CT was utilized to diagnose COVID-19-related pneumonia. This resulted in a significant rise in adoption during COVID-19.

Nonetheless, there is expected to be a major increase in public knowledge of preventative medicines, but the future appears to be uncertain.

The demand for contrast media injectors will be largely determined by the amount of diagnostic imaging and the number of CT and MRI machines installed. We should expect diagnostic imaging demand to return to baseline in a few months, which might lead to a rebound in contrast injector demand.

The Covid-19 had a significant influence on the contrast media injector market in 2020, with sales dropping by roughly 20%. By 2022, the market is expected to return to its previous highs.

Country-wise Insights

What Makes the U.S. a Large Market for Contrast media injectors?

The U.S. is estimated to account for around 89.5% of the North America contrast media injectors market in 2022. 

U.S. dominates the contrast media injectors market owing to favorable reimbursement policies, increase ageing population, rise in the regulatory approval of an increasing number of contrast agents and increasing government funding. The healthcare business in the U.S. is one of the well-known markets, in terms of product accessibility and innovations.

Additionally, increasing incidences of trauma cases globally is expected to fuel revenue growth of the contrast media injectors market over the forecast period in the region.

According to the American Association for the Surgery of Trauma reported data, in 2020, trauma accounts for nearly 40 Mn homicide and suicide deaths each year in the US occurred due to trauma. Trauma is the fourth-leading cause of death across all age groups across the globe.

Diagnostics imaging is recommended in trauma cases to detect damage to internal organs as well as severity of the damage. Increasing trauma cases globally is expected to boost growth of the contrast media injectors market.

Furthermore, in the approaching years, the expanding IT-enabled solutions in U.S for contrast media injectors will present additional potential development prospects for this market.

Why is Germany Considered a Lucrative Contrast media injectors Market?

Germany is estimated to account for 25.8% of the Western Europe contrast media injectors market in 2022, as a result of a well-established healthcare infrastructure.

Furthermore, market expansion is fueled by factors such as a rising demand for minimally invasive treatments and an increase in the incidence of chronic illnesses as a consequence of changing lifestyles.

Additionally, increasing prevalence of cancer among the geriatric population globally is expected to drive demand for contrast media injectors market.

According to reported data in 2020, by National Cancer Institute from their research, around 40% lives could be saved each year, by early diagnosis of cancer.

 What are the Factors Fueling the Demand for Contrast media injectors in China?

The contrast media injectors market in China is estimated to be worth 53.1% market share in 2022 in the APEJ market owing to increased R&D investments, favorable demographic scenario.

In emerging country like China, the growing demand for quality healthcare facilities and high patient population with chronic diseases are the major factors expected to provide enormous opportunities for the manufacturers to expand their business in this region.

According to the latest reported data by world health organization, in 2020, non-communicable diseases account for an estimated 80% of total deaths and 70% of disability-adjusted life years lost in China. This is the area where diagnosis play an important role which is expected to lead the market growth in China.

How will the Contrast media injectors Market Expand across India?

Contrast media injectors in India is expected to have nearly 15.0% market share in the global market in 2022. The expansion of this sector is being driven by increased investment in the Indian radiology industry, increased emphasis of market participants, and increased government assistance to boost healthcare service delivery.

India is anticipated to grow at an impressive rate as patients are searching for low cost diagnosis with outpatient imaging. Demand for outpatient imaging is continuously increasing because the diagnostic centers offer more relaxed, personalized service and liberties which is more accepted by patient. CT and MRI growth have been exceptional, increasing at a rate of about 200% over the past 10 years.

Outpatient facilities are usually far less expensive than hospitals, as they offer discounts given by diagnostic centers which increases the demand and give opportunities for players to increase their production.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Category-wise Insights

Demand for CT Injectors continue gaining Traction

By Product, CT Injectors are anticipated to hold the maximum share of 43.0% in 2022 owing to their ability to aid in 3D visual reconstruction.

CT injectors are used to inject iodine-based contrast media for computed tomography procedure. Adoption of CT injectors for insertion of contrast media for various procedures such as X-ray and ultrasound is increasing.

CT injectors are used to enhance image quality while also increasing patient safety. These devices regulate contrast dose, keep track of how much is used, and accelerate injections to keep up with rapid CT scanners and alert users to possible dangers such as air embolisms or extravasations.

Why Hospital projected maximum growth in the Contrast media injectors Market?

By End User, Hospital pharmacies segment is anticipated to hold the maximum share of 49.4% in 2022. Hospitals have access to modern medical technology and its infrastructure is capable of delivering high-quality care for any disease condition. Hospitals are expected to account for a significant portion of the market, as the majority of people in both emerging and established countries prefer to visit hospitals for any health-related issue.

Additionally, the expanding number of hospitals and increased accessibility in emerging countries are expected to provide profitable prospects for the hospital segment to grow throughout the forecast period.

Furthermore, as the number of cancer, neurological, and cardiovascular patients admitted to hospitals rises, the industry will experience significant growth. The vast range of applications in radiology, interventional radiology, and interventional cardiology, hospitals are the principal users of high pressure contrast media injectors.

Competitive Landscape

Companies operating in the contrast media injectors market are competitive by nature, with a presence of few players. These players are involved in a number of strategic alliances.

The contrast media injector’s market players are trying out every possible mode of organic/inorganic growth to sustain themselves in the market. The product launch and acquisition accelerates the manufacturer’s strategy to capitalize on the market share and capture the significant share of market. Some of the recent instances include:

  • In May 2021, Bayer AG announced a collaboration with ArcherDX, Inc., which will focus on the global development and commercialization of therapy-accompanying diagnostic tests – also known as companion diagnostics (CDx) – for Vitrakvi™ (larotrectinib), based on next-generation sequencing.
  • In May 2019, the ulrich’s CT contrast agent injector, CT motion, was made available in the world's most important medical technology market, the U.S. 

Scope of the Report

Attribute

Details

Forecast Period

2014-2021

Historical Data Available for

2022-2030

Market Analysis

USD Billion for Value and Units for Volume

Key Countries Covered

US, Canada, Brazil, Mexico, Germany, U.K., France, Italy, Spain, Poland, Russia, Greater China , Japan, India, Australia, New Zealand, GCC Countries, South Africa

Key Segments Covered

Product, End User and Region

Key Companies Profiled

  • Mallinckrodt (Guerbet SA)
  • GE Healthcare
  • Bayer AG
  • Ulrich GmbH & Co. KG
  • Bracco Imaging S.p.A
  • Medtron
  • Nemoto Kyorindo Co. Ltd
  • Shenzhen Anke High-tech Co. Ltd

Report Coverage

Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives

Customization & Pricing

Available upon Request

Contrast Media Injectors Market by Category

By Product:

  • CT Injectors
  • MRI Injectors
  • Cardio Injectors

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostics Centers

By Region:

  • North America
  • Latin America
  • Eastern Europe
  • Western Europe
  • APEJ
  • Japan
  • Middle East and Africa (MEA)

Frequently Asked Questions

The global contrast media injectors market is worth US$ 1.4 Bn in 2021 and is set to expand 1.6X over the forecasted years owing to the rising number of cardiac disorders and rising prevalence of cardiovascular disease cases.

The sales of contrast media injectors in the market have grown at a CAGR of nearly 5.4% between 2014 and 2021. The need for contrast media injectors is growing because of increasing physicians preference about the benefits related with contrast media injectable diagnosis.

The contrast media injectors market is expected to reach US$ 2.4 Bn by the end of 2030 with sales revenue expected to register CAGR of 6.2% over the forecast period.

North America currently holds the largest market share in the contrast media injectors. U.S. being the leading contributor with a market value over US$ 470.3 Mn in 2022.

Demand of contrast media injectors market is expected to register growth in Western Europe at rate of 6.0% CAGR during the forecast period.

The contrast media injectors in China is likely to observe growth with an impressive market share of 53.1% in 2022 in APEJ market.

Rising adoption of technological advanced CT scan, growth of diagnostic imaging centers, and collaboration as the key strategy to expand the business are driving the sales of contrast media injectors market across the globe.

U.S., Japan, Germany, Greater China, and U.K. are the top 5 countries that are driving the demand for contrast media injectors market.

Leading companies of contrast media injectors are Bayer AG, Nemoto Kyorindo Co. Ltd., Mallinckrodt, Bracco Imaging, Ulrich GmBh, Guerbet SA, Medtron AG,

Table of Content

1. Assumptions & Acronyms Used

2. Research Methodology

3. Executive Summary

4. Market Overview

    4.1. Introduction

        4.1.1. Market Taxonomy & Market Definition

    4.2. Contrast Media Injectors Market Product Overview

    4.3. Contrast Media Injectors Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunity

        4.3.4. Trends

5. Global Contrast Media Injectors Market Forecast, 2014-2030

    5.1. Introduction

        5.1.1. Y-o-Y Growth Projection

        5.1.2. Absolute $ Opportunity

    5.2. Parent Market Overview

        5.2.1. Introduction

            5.2.1.1. Y-o-Y Growth Projection

            5.2.1.2. Absolute $ Opportunity

    5.3. Contrast Media Injectors Market Trends

    5.4. Regional Average Pricing Analysis (2021)

    5.5. Global Contrast Media Injectors Market Snapshot (2022)

6. Global Contrast Media Injectors Market Analysis, By Product

    6.1. Introduction

        6.1.1. Y-o-Y Growth Comparison, By Product

        6.1.2. BPS Analysis, By Product

    6.2. Market Value and Volume Forecast, By Product

        6.2.1. CT Injectors

            6.2.1.1. Absolute $ Opportunity

            6.2.1.2. Market Value Forecast

        6.2.2. MRI Injectors

            6.2.2.1. Absolute $ Opportunity

            6.2.2.2. Market Value Forecast

        6.2.3. Cardiology Injectors

            6.2.3.1. Absolute $ Opportunity

            6.2.3.2. Market Value Forecast

    6.3. Global Contrast Media Injectors Market Attractiveness Analysis, by Product Segment

7. Global Contrast Media Injectors Market Analysis, By End User

    7.1. Introduction

        7.1.1. Y-o-Y Growth Comparison, By End User

        7.1.2. BPS Analysis, By End User

    7.2. Market Value and Volume Forecast, By End User

        7.2.1. Hospitals

            7.2.1.1. Absolute $ Opportunity

            7.2.1.2. Market Value Forecast

        7.2.2. Ambulatory Surgical Centres

            7.2.2.1. Absolute $ Opportunity

            7.2.2.2. Market Value Forecast

        7.2.3. Diagnostics Centres

            7.2.3.1. Absolute $ Opportunity

            7.2.3.2. Market Value Forecast

    7.3. Global Contrast Media Injectors Market Attractiveness Analysis, by End User Segment

8. Global Contrast Media Injectors Market Analysis, By Region

    8.1. Introduction

        8.1.1. Y-o-Y Growth Comparison, By Region

        8.1.2. BPS Analysis, By Region

    8.2. Market Value and Volume Forecast, By Region

        8.2.1. North America

        8.2.2. Latin America

        8.2.3. Western Europe

        8.2.4. Eastern Europe

        8.2.5. APEJ

        8.2.6. Japan

        8.2.7. MEA

    8.3. Global Contrast Media Injectors Market Attractiveness Analysis, by Region

9. North America Contrast Media Injectors Market Analysis

    9.1. Introduction

        9.1.1. Y-o-Y Growth Comparison

            9.1.1.1. By Country

            9.1.1.2. By Product

            9.1.1.3. By End User

        9.1.2. BPS Analysis

            9.1.2.1. By Country

            9.1.2.2. By Product

            9.1.2.3. By End User

    9.2. North America Market Forecast, By Country

        9.2.1. U.S.

            9.2.1.1. Absolute $ Opportunity

            9.2.1.2. Market Value Forecast

        9.2.2. Canada

            9.2.2.1. Absolute $ Opportunity

            9.2.2.2. Market Value Forecast

    9.3. North America Market Forecast, By Product

        9.3.1. CT Injectors

            9.3.1.1. Absolute $ Opportunity

            9.3.1.2. Market Value Forecast

        9.3.2. MRI Injectors

            9.3.2.1. Absolute $ Opportunity

            9.3.2.2. Market Value Forecast

        9.3.3. Cardiology Injectors

            9.3.3.1. Absolute $ Opportunity

            9.3.3.2. Market Value Forecast

    9.4. North America Market Forecast, By End User

        9.4.1. Hospitals

            9.4.1.1. Absolute $ Opportunity

            9.4.1.2. Market Value Forecast

        9.4.2. Ambulatory Surgical Centres

            9.4.2.1. Absolute $ Opportunity

            9.4.2.2. Market Value Forecast

        9.4.3. Diagnostics Centres

            9.4.3.1. Absolute $ Opportunity

            9.4.3.2. Market Value Forecast

    9.5. North America Market Trends and Impact Analysis of Drivers & Restraints

10. Latin America Contrast Media Injectors Market Analysis

    10.1. Introduction

        10.1.1. Y-o-Y Growth Comparison

            10.1.1.1. By Country

            10.1.1.2. By Product

            10.1.1.3. By End User

        10.1.2. BPS Analysis

            10.1.2.1. By Country

            10.1.2.2. By Product

            10.1.2.3. By End User

    10.2. Latin America Market Forecast, By Country

        10.2.1. Mexico

            10.2.1.1. Absolute $ Opportunity

            10.2.1.2. Market Value Forecast

        10.2.2. Brazil

            10.2.2.1. Absolute $ Opportunity

            10.2.2.2. Market Value Forecast

        10.2.3. Rest of Latin America

            10.2.3.1. Absolute $ Opportunity

            10.2.3.2. Market Value Forecast

    10.3. Latin America Market Forecast, By Product

        10.3.1. CT Injectors

            10.3.1.1. Absolute $ Opportunity

            10.3.1.2. Market Value Forecast

        10.3.2. MRI Injectors

            10.3.2.1. Absolute $ Opportunity

            10.3.2.2. Market Value Forecast

        10.3.3. Cardiology Injectors

            10.3.3.1. Absolute $ Opportunity

            10.3.3.2. Market Value Forecast

    10.4. Latin America Market Forecast, By End User

        10.4.1. Hospitals

            10.4.1.1. Absolute $ Opportunity

            10.4.1.2. Market Value Forecast

        10.4.2. Ambulatory Surgical Centres

            10.4.2.1. Absolute $ Opportunity

            10.4.2.2. Market Value Forecast

        10.4.3. Diagnostics Centres

            10.4.3.1. Absolute $ Opportunity

            10.4.3.2. Market Value Forecast

    10.5. Latin America Market Trends and Impact Analysis of Drivers & Restraints

11. Western Europe Contrast Media Injectors Market Analysis

    11.1. Introduction

        11.1.1. Y-o-Y Growth Comparison

            11.1.1.1. By Country

            11.1.1.2. By Product

            11.1.1.3. By End User

        11.1.2. BPS Analysis

            11.1.2.1. By Country

            11.1.2.2. By Product

            11.1.2.3. By End User

    11.2. Western Europe Market Forecast, By Country

        11.2.1. Germany

            11.2.1.1. Absolute $ Opportunity

            11.2.1.2. Market Value Forecast

        11.2.2. France

            11.2.2.1. Absolute $ Opportunity

            11.2.2.2. Market Value Forecast

        11.2.3. U.K.

            11.2.3.1. Absolute $ Opportunity

            11.2.3.2. Market Value Forecast

        11.2.4. Spain

            11.2.4.1. Absolute $ Opportunity

            11.2.4.2. Market Value Forecast

        11.2.5. Italy

            11.2.5.1. Absolute $ Opportunity

            11.2.5.2. Market Value Forecast

        11.2.6. Rest of Western Europe

            11.2.6.1. Absolute $ Opportunity

            11.2.6.2. Market Value Forecast

    11.3. Western Europe Market Forecast, By Product

        11.3.1. CT Injectors

            11.3.1.1. Absolute $ Opportunity

            11.3.1.2. Market Value Forecast

        11.3.2. MRI Injectors

            11.3.2.1. Absolute $ Opportunity

            11.3.2.2. Market Value Forecast

        11.3.3. Cardiology Injectors

            11.3.3.1. Absolute $ Opportunity

            11.3.3.2. Market Value Forecast

    11.4. Western Europe Market Forecast, By End User

        11.4.1. Hospitals

            11.4.1.1. Absolute $ Opportunity

            11.4.1.2. Market Value Forecast

        11.4.2. Ambulatory Surgical Centres

            11.4.2.1. Absolute $ Opportunity

            11.4.2.2. Market Value Forecast

        11.4.3. Diagnostics Centres

            11.4.3.1. Absolute $ Opportunity

            11.4.3.2. Market Value Forecast

    11.5. Western Europe Market Trends and Impact Analysis of Drivers & Restraints

12. Eastern Europe Contrast Media Injectors Market Analysis

    12.1. Introduction

        12.1.1. Y-o-Y Growth Comparison

            12.1.1.1. By Country

            12.1.1.2. By Product

            12.1.1.3. By End User

        12.1.2. BPS Analysis

            12.1.2.1. By Country

            12.1.2.2. By Product

            12.1.2.3. By End User

    12.2. Eastern Europe Market Forecast, By Country

        12.2.1. Russia

            12.2.1.1. Absolute $ Opportunity

            12.2.1.2. Market Value Forecast

        12.2.2. Poland

            12.2.2.1. Absolute $ Opportunity

            12.2.2.2. Market Value Forecast

        12.2.3. Rest of Eastern Europe

            12.2.3.1. Absolute $ Opportunity

            12.2.3.2. Market Value Forecast

    12.3. Eastern Europe Market Forecast, By Product

        12.3.1. CT Injectors

            12.3.1.1. Absolute $ Opportunity

            12.3.1.2. Market Value Forecast

        12.3.2. MRI Injectors

            12.3.2.1. Absolute $ Opportunity

            12.3.2.2. Market Value Forecast

        12.3.3. Cardiology Injectors

            12.3.3.1. Absolute $ Opportunity

            12.3.3.2. Market Value Forecast

    12.4. Eastern Europe Market Forecast, By End User

        12.4.1. Hospitals

            12.4.1.1. Absolute $ Opportunity

            12.4.1.2. Market Value Forecast

        12.4.2. Ambulatory Surgical Centres

            12.4.2.1. Absolute $ Opportunity

            12.4.2.2. Market Value Forecast

        12.4.3. Diagnostics Centres

            12.4.3.1. Absolute $ Opportunity

            12.4.3.2. Market Value Forecast

    12.5. Eastern Europe Market Trends and Impact Analysis of Drivers & Restraints

13. APEJ Contrast Media Injectors Market

    13.1. Introduction

        13.1.1. Y-o-Y Growth Comparison

            13.1.1.1. By Country

            13.1.1.2. By Product

            13.1.1.3. By End User

        13.1.2. BPS Analysis

            13.1.2.1. By Country

            13.1.2.2. By Product

            13.1.2.3. By End User

    13.2. APEJ Market Forecast, By Country

        13.2.1. Greater China

            13.2.1.1. Absolute $ Opportunity

            13.2.1.2. Market Value Forecast

        13.2.2. India

            13.2.2.1. Absolute $ Opportunity

            13.2.2.2. Market Value Forecast

        13.2.3. Australia and New Zealand

            13.2.3.1. Absolute $ Opportunity

            13.2.3.2. Market Value Forecast

        13.2.4. Rest of APEJ

            13.2.4.1. Absolute $ Opportunity

            13.2.4.2. Market Value Forecast

    13.3. APEJ Market Forecast, By Product

        13.3.1. CT Injectors

            13.3.1.1. Absolute $ Opportunity

            13.3.1.2. Market Value Forecast

        13.3.2. MRI Injectors

            13.3.2.1. Absolute $ Opportunity

            13.3.2.2. Market Value Forecast

        13.3.3. Cardiology Injectors

            13.3.3.1. Absolute $ Opportunity

            13.3.3.2. Market Value Forecast

    13.4. APEJ Market Forecast, By End User

        13.4.1. Hospitals

            13.4.1.1. Absolute $ Opportunity

            13.4.1.2. Market Value Forecast

        13.4.2. Ambulatory Surgical Centres

            13.4.2.1. Absolute $ Opportunity

            13.4.2.2. Market Value Forecast

        13.4.3. Diagnostics Centres

            13.4.3.1. Absolute $ Opportunity

            13.4.3.2. Market Value Forecast

    13.5. APEJ Market Trends and Impact Analysis of Drivers & Restraints

14. Japan Contrast Media Injectors Market

    14.1. Introduction

        14.1.1. Y-o-Y Growth Comparison

            14.1.1.1. By Product

            14.1.1.2. By End User

        14.1.2. BPS Analysis

            14.1.2.1. By Product

            14.1.2.2. By End User

    14.2. Japan Market Forecast, By Product

        14.2.1. CT Injectors

            14.2.1.1. Absolute $ Opportunity

            14.2.1.2. Market Value Forecast

        14.2.2. MRI Injectors

            14.2.2.1. Absolute $ Opportunity

            14.2.2.2. Market Value Forecast

        14.2.3. Cardiology Injectors

            14.2.3.1. Absolute $ Opportunity

            14.2.3.2. Market Value Forecast

    14.3. Japan Market Forecast, By End User

        14.3.1. Hospitals

            14.3.1.1. Absolute $ Opportunity

            14.3.1.2. Market Value Forecast

        14.3.2. Ambulatory Surgical Centres

            14.3.2.1. Absolute $ Opportunity

            14.3.2.2. Market Value Forecast

        14.3.3. Diagnostics Centres

            14.3.3.1. Absolute $ Opportunity

            14.3.3.2. Market Value Forecast

    14.4. Japan Market Trends and Impact Analysis of Drivers & Restraints

15. MEA Contrast Media Injectors Market

    15.1. Introduction

        15.1.1. Y-o-Y Growth Comparison

            15.1.1.1. By Country

            15.1.1.2. By Product

            15.1.1.3. By End User

        15.1.2. BPS Analysis

            15.1.2.1. By Country

            15.1.2.2. By Product

            15.1.2.3. By End User

    15.2. MEA Market Forecast, By Country

        15.2.1. GCC

            15.2.1.1. Absolute $ Opportunity

            15.2.1.2. Market Value Forecast

        15.2.2. South Africa

            15.2.2.1. Absolute $ Opportunity

            15.2.2.2. Market Value Forecast

        15.2.3. Rest of MEA

            15.2.3.1. Absolute $ Opportunity

            15.2.3.2. Market Value Forecast

    15.3. MEA Market Forecast, By Product

        15.3.1. CT Injectors

            15.3.1.1. Absolute $ Opportunity

            15.3.1.2. Market Value Forecast

        15.3.2. MRI Injectors

            15.3.2.1. Absolute $ Opportunity

            15.3.2.2. Market Value Forecast

        15.3.3. Cardiology Injectors

            15.3.3.1. Absolute $ Opportunity

            15.3.3.2. Market Value Forecast

    15.4. MEA Market Forecast, By End User

        15.4.1. Hospitals

            15.4.1.1. Absolute $ Opportunity

            15.4.1.2. Market Value Forecast

        15.4.2. Ambulatory Surgical Centres

            15.4.2.1. Absolute $ Opportunity

            15.4.2.2. Market Value Forecast

        15.4.3. Diagnostics Centres

            15.4.3.1. Absolute $ Opportunity

            15.4.3.2. Market Value Forecast

    15.5. MEA Market Trends and Impact Analysis of Drivers & Restraints

16. Competitive Landscape

    16.1. Competition Dashboard

    16.2. Company Share Analysis

    16.3. Mallinckrodt

    16.4. Guerbet SA

    16.5. Bayer AG

    16.6. Bracco Imaging S.p.A.

    16.7. Ulrich GmbH & Co. KG

    16.8. Medtron

    16.9. Nemoto Kyorindo Co. Ltd

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Contrast Media Injectors Market Value Forecast, by Product Segment, 2014–2030 (US$ Mn)

Table 2: Global Contrast Media Injectors Market Volume Forecast, by Product Segment, 2014–2030 (Units)

Table 3: Global Contrast Media Injectors Market Value Forecast, by End User, 2014–2030 (US$ Mn)

Table 4: Global Contrast Media Injectors Market Volume Forecast, by End User, 2014–2030 (Units)

Table 5: Global Contrast Media Injectors Market Value Forecast By Region, 2014–2030 (US$ Mn)

Table 6: Global Contrast Media Injectors Market Volume Forecast By Region, 2014–2030 (Units)

Table 7: North America Contrast Media Injectors Market Value Forecast, by Country, 2014–2030 (US$ Mn)

Table 8: North America Contrast Media Injectors Market Value Forecast, by Product, 2014–2030 (US$ Mn)

Table 9: North America Contrast Media Injectors Market Volume Forecast, by Product, 2014–2030 (Units)

Table 10: Latin America Contrast Media Injectors Market Value Forecast, by Country, 2014–2030 (US$ Mn)

Table 11: Latin America Contrast Media Injectors Market Value Forecast, by Product, 2014–2030 (US$ Mn)

Table 12: Latin America Contrast Media Injectors Market Volume Forecast, by Product, 2014–2030 (Units)

Table 13: Western Europe Contrast Media Injectors Market Value Forecast, by Country, 2014–2030 (US$ Mn)

Table 14: Western Europe Contrast Media Injectors Market Value Forecast, by Product, 2014–2030 (US$ Mn)

Table 15: Western Europe Contrast Media Injectors Market Volume Forecast, by Product, 2014–2030 (Units)

Table 16: Eastern Europe Contrast Media Injectors Market Value Forecast, by Country, 2014–2030 (US$ Mn)

Table 17: Eastern Europe Contrast Media Injectors Market Value Forecast, by Product, 2014–2030 (US$ Mn)

Table 18: Eastern Europe Contrast Media Injectors Market Volume Forecast, by Product, 2014–2030 (Units)

Table 19: APEJ Contrast Media Injectors Market Value Forecast, by Country, 2014–2030 (US$ Mn)

Table 20: APEJ Contrast Media Injectors Market Value Forecast, by Product, 2014–2030 (US$ Mn)

Table 21: APEJ Contrast Media Injectors Market Volume Forecast, by Product, 2014–2030 (Units)

Table 22: Japan Contrast Media Injectors Market Value Forecast, by Product, 2014–2030 (US$ Mn)

Table 23: Japan Contrast Media Injectors Market Volume Forecast, by Product, 2014–2030 (Units)

Table 24: MEA Contrast Media Injectors Market Value Forecast, by Country, 2014–2030 (US$ Mn)

Table 25: MEA Contrast Media Injectors Market Value Forecast, by Product, 2014–2030 (US$ Mn)

Table 26: MEA Contrast Media Injectors Market Volume Forecast, by Product, 2014–2030 (Units)

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

​Figure 1: Global Contrast Media Injectors Market,

Figure 2: Global Diagnostics Imaging Devices Market Value Forecast, 2014–2030 (US$ Mn)

Figure 3:  Global CT Contrast Media Injectors Price Difference (US$), by Region, 2021

Figure 4:  Global CT Contrast Media Injectors Price Difference (US$), by Region, 2030

Figure 5:  Global MRI Contrast Media Injectors Price Difference (US$), by Region, 2021

Figure 6:  Global MRI Contrast Media Injectors Price Difference (US$), by Region, 2030

Figure 7:  Global Cardiology Contrast Media Injectors Price Difference (US$), by Region, 2021

Figure 8:  Global Cardiology Contrast Media Injectors Price Difference (US$), by Region, 2030

Figure 9: Global Contrast Media Injectors Market Value Share, by Product Segment, 2014–2030 

Figure 10: Global Contrast Media Injectors Market Y-o-Y Growth Rate, by Product Segment, 2014–2030

Figure 11: Global Contrast Media Injectors Market Value (US$ Mn) & 

Figure 12: Global Contrast Media Injectors Market Absolute $ Opportunity 

Figure 13: Global Contrast Media Injectors Market Value (US$ Mn) & 

Figure 14: Global Contrast Media Injectors Market Absolute $ Opportunity 

Figure 15: Global Contrast Media Injectors Market Value (US$ Mn) & 

Figure 16: Global Contrast Media Injectors Market Absolute $ Opportunity 

Figure 17: Global Contrast Media Injectors Market Attractiveness Analysis, by Product Segment, 2014–2030

Figure 18: Global Contrast Media Injectors Market Value Share, by End User, 2014–2030 

Figure 19: Global Contrast Media Injectors Market Y-o-Y Growth Rate, by End User, 2014–2030

Figure 20: Global Contrast Media Injectors Market Value (US$ Mn) & 

Figure 21: Global Contrast Media Injectors Market Absolute $ Opportunity 

Figure 22: Global Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y  Growth, by ASCs End User Segment, 2014–2030

Figure 23: Global Contrast Media Injectors Market Absolute $ Opportunity 

Figure 24: Global Contrast Media Injectors Market Value (US$ Mn) & 

Figure 25: Global Contrast Media Injectors Market Absolute $ Opportunity 

Figure 26: Global Contrast Media Injectors Market Attractiveness Analysis, by End User, 2014–2030

Figure 27: Global Contrast Media Injectors Market Value Share, by Region, 2014–2030 

Figure 28: Global Contrast Media Injectors Market Y-o-Y Growth Rate, by Region, 2014–2030

Figure 29: Global Contrast Media Injectors Market Attractiveness Analysis, by Region, 2014–2030

Figure 30: North America Contrast Media Injectors Market Y-o-Y Growth Rate, by Country, 2014–2030

Figure 31: North America Contrast Media Injectors Market Value Share, by Country, 2014–2030 

Figure 32: North America Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by the U.S., 2014–2030

Figure 33: North America Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by the U.S., 2014–2030

Figure 34: North America Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Canada, 2014–2030

Figure 35: North America Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Canada, 2014–2030

Figure 36: North America Contrast Media Injectors Market Attractiveness Analysis, by Country, 2014–2030

Figure 37: North America Contrast Media Injectors Market Y-o-Y Growth Rate, by Product Segment, 2014–2030

Figure 38: North America Contrast Media Injectors Market Value Share, by Product Segment, 2014–2030 

Figure 39: North America Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by CT Injectors Product Segment, 2014–2030

Figure 40: North America Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by CT Injectors Product Segment, 2014–2030

Figure 41: North America Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by MRI Injectors Product Segment, 2014–2030

Figure 42: North America Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by MRI Injectors Product Segment, 2014–2030

Figure 43: North America Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Cardiology Injectors Product Segment, 2014–2030

Figure 44: North America Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Cardiology Injectors Product Segment, 2014–2030

Figure 45: North America Contrast Media Injectors Market Attractiveness Analysis, by Product Segment, 2014–2030

Figure 46: North America Contrast Media Injectors Market Value Share, by End User, 2014–2030 

Figure 47: North America Contrast Media Injectors Market Y-o-Y Growth Rate, by End User, 2014–2030

Figure 48: North America Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Hospitals End User Segment, 2014–2030

Figure 49: North America Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Hospitals End User Segment, 2014–2030

Figure 50: North America Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by ASCs End User Segment, 2014–2030

Figure 51: North America Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by ASCs End User Segment, 2014–2030

Figure 52: North America Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Diagnostic Centres End User Segment, 2014–2030

Figure 53: North America Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Diagnostic Centres End User Segment, 2014–2030

Figure 54: North America Contrast Media Injectors Market Attractiveness Analysis, by End User, 2014–2030

Figure 55: Latin America Contrast Media Injectors Market Y-o-Y Growth Rate, by Country, 2014–2030

Figure 56: Latin America Contrast Media Injectors Market Value Share, by Country, 2014–2030 

Figure 57: Latin America Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Mexico, 2014–2030

Figure 58: Latin America Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Mexico, 2014–2030

Figure 59: Latin America Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Brazil, 2014–2030

Figure 60: Latin America Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Brazil, 2014–2030

Figure 61: Latin America Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Rest of Latin America, 2014–2030

Figure 62: Latin America Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Rest of Latin America, 2014–2030

Figure 63: Latin America Contrast Media Injectors Market Attractiveness Analysis, by Country, 2014–2030

Figure 64: Latin America Contrast Media Injectors Market Y-o-Y Growth Rate, by Product Segment, 2014–2030

Figure 65: Latin America Contrast Media Injectors Market Value Share, by Product Segment, 2014–2030 

Figure 66: Latin America Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by CT Injectors Product Segment, 2014–2030

Figure 67: Latin America Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by CT Injectors Product Segment, 2014–2030

Figure 68: Latin America Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by MRI Injectors Product Segment, 2014–2030

Figure 69: Latin America Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by MRI Injectors Product Segment, 2014–2030

Figure 70: Latin America Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Cardiology Injectors Product Segment, 2014–2030

Figure 71: Latin America Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Cardiology Injectors Product Segment, 2014–2030

Figure 72: Latin America Contrast Media Injectors Market Attractiveness Analysis, by Product Segment, 2014–2030

Figure 73: Latin America Contrast Media Injectors Market Value Share, by End User, 2014–2030 

Figure 74: Latin America Contrast Media Injectors Market Y-o-Y Growth Rate, by End User, 2014–2030

Figure 75: Latin America Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Hospitals End User Segment, 2014–2030

Figure 76: Latin America Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Hospitals End User Segment, 2014–2030

Figure 77: Latin America Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by ASCs End User Segment, 2014–2030

Figure 78: Latin America Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by ASCs End User Segment, 2014–2030

Figure 79: Latin America Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Diagnostic Centres End User Segment, 2014–2030

Figure 80: Latin America Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Diagnostic Centres End User Segment, 2014–2030

Figure 81: Latin America Contrast Media Injectors Market Attractiveness Analysis, by End User, 2014–2030

Figure 82: Western Europe Contrast Media Injectors Market Y-o-Y Growth Rate, by Country, 2014–2030

Figure 83: Western Europe Contrast Media Injectors Market Value Share, by Country, 2014–2030 

Figure 84: Western Europe Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Germany, 2014–2030

Figure 85: Western Europe Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Germany, 2014–2030

Figure 86: Western Europe Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by France, 2014–2030

Figure 87: Western Europe Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by France, 2014–2030

Figure 88: Western Europe Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by The U.K., 2014–2030

Figure 89: Western Europe Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by The U.K., 2014–2030

Figure 90: Western Europe Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Spain, 2014–2030

Figure 91: Western Europe Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Spain, 2014–2030

Figure 92: Western Europe Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Italy, 2014–2030

Figure 93: Western Europe Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Italy, 2014–2030

Figure 94: Western Europe Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Rest of Western Europe, 2014–2030

Figure 95: Western Europe Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Rest of Western Europe, 2014–2030

Figure 96: Western Europe Contrast Media Injectors Market Attractiveness Analysis, by Country, 2014–2030

Figure 97: Western Europe Contrast Media Injectors Market Y-o-Y Growth Rate, by Product Segment, 2014–2030

Figure 98: Western Europe Contrast Media Injectors Market Value Share, by Product Segment, 2014–2030 

Figure 99: Western Europe Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by CT Injectors Product Segment, 2014–2030

Figure 100: Western Europe Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by CT Injectors Product Segment, 2014–2030

Figure 101: Western Europe Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by MRI Injectors Product Segment, 2014–2030

Figure 102: Western Europe Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by MRI Injectors Product Segment, 2014–2030

Figure 103: Western Europe Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Cardiology Injectors Product Segment, 2014–2030

Figure 104: Western Europe Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Cardiology Injectors Product Segment, 2014–2030

Figure 105: Western Europe Contrast Media Injectors Market Attractiveness Analysis, by Product Segment, 2014–2030

Figure 106: Western Europe Contrast Media Injectors Market Value Share, by End User, 2014–2030 

Figure 107: Western Europe Contrast Media Injectors Market Y-o-Y Growth Rate, by End User, 2014–2030

Figure 108: Western Europe Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Hospitals End User Segment, 2014–2030

Figure 109: Western Europe Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Hospitals End User Segment, 2014–2030

Figure 110: Western Europe Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by ASCs End User Segment, 2014–2030

Figure 111: Western Europe Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by ASCs End User Segment, 2014–2030

Figure 112: Western Europe Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Diagnostic Centres End User Segment, 2014–2030

Figure 113: Western Europe Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Diagnostic Centres End User Segment, 2014–2030

Figure 114: Western Europe Contrast Media Injectors Market Attractiveness Analysis, by End User, 2014–2030

Figure 115: Eastern Europe Contrast Media Injectors Market Value Share, by Country, 2014–2030 

Figure 116: Eastern Europe Contrast Media Injectors Market Y-o-Y Growth Rate, by Country, 2014–2030

Figure 117: Eastern Europe Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Poland, 2014–2030

Figure 118: Eastern Europe Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Poland, 2014–2030

Figure 119: Eastern Europe Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Russia, 2014–2030

Figure 120: Eastern Europe Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Russia, 2014–2030

Figure 121: Eastern Europe Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Rest of Eastern Europe, 2014–2030

Figure 122: Eastern Europe Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Rest of Eastern Europe, 2014–2030

Figure 123: Eastern Europe Contrast Media Injectors Market Attractiveness Analysis, by Country, 2014–2030

Figure 124: Eastern Europe Contrast Media Injectors Market Y-o-Y Growth Rate, by Product Segment, 2014–2030

Figure 125: Eastern Europe Contrast Media Injectors Market Value Share, by Product Segment, 2014–2030 

Figure 126: Eastern Europe Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by CT Injectors Product Segment, 2014–2030

Figure 127: Eastern Europe Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by CT Injectors Product Segment, 2014–2030

Figure 128: Eastern Europe Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by MRI Injectors Product Segment, 2014–2030

Figure 129: Eastern Europe Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by MRI Injectors Product Segment, 2014–2030

Figure 130: Eastern Europe Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Cardiology Injectors Product Segment, 2014–2030

Figure 131: Eastern Europe Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Cardiology Injectors Product Segment, 2014–2030

Figure 132: Eastern Europe Contrast Media Injectors Market Attractiveness Analysis, by Product Segment, 2014–2030

Figure 133: Eastern Europe Contrast Media Injectors Market Value Share, by End User, 2014–2030 

Figure 134: Eastern Europe Contrast Media Injectors Market Y-o-Y Growth Rate, by End User, 2014–2030

Figure 135: Eastern Europe Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Hospitals End User Segment, 2014–2030

Figure 136: Eastern Europe Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Hospitals End User Segment, 2014–2030

Figure 137: Eastern Europe Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by ASCs End User Segment, 2014–2030

Figure 138: Eastern Europe Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by ASCs End User Segment, 2014–2030

Figure 139: Eastern Europe Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Diagnostic Centres End User Segment, 2014–2030

Figure 140: Eastern Europe Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Diagnostic Centres End User Segment, 2014–2030

Figure 141: Eastern Europe Contrast Media Injectors Market Attractiveness Analysis, by End User, 2014–2030

Figure 142: APEJ Contrast Media Injectors Market Value Share, by Country, 2014–2030 

Figure 143: APEJ Contrast Media Injectors Market Y-o-Y Growth Rate, by Country, 2014–2030

Figure 144: APEJ Contrast Media Injectors Market Value (US$ Mn) & 

Figure 145: APEJ Contrast Media Injectors Market Absolute $ Opportunity 

Figure 146: APEJ Contrast Media Injectors Market Value (US$ Mn) & 

Figure 147: APEJ Contrast Media Injectors Market Absolute $ Opportunity 

Figure 148: APEJ Contrast Media Injectors Market Value (US$ Mn) & 

Figure 149: APEJ Contrast Media Injectors Market Absolute $ Opportunity 

Figure 150: APEJ Contrast Media Injectors Market Value (US$ Mn) & 

Figure 151: APEJ Contrast Media Injectors Market Absolute $ Opportunity 

Figure 152: APEJ Contrast Media Injectors Market Attractiveness Analysis, by Country, 2014–2030

Figure 153: APEJ Contrast Media Injectors Market Y-o-Y Growth Rate, by Product Segment, 2014–2030

Figure 154: APEJ Contrast Media Injectors Market Value Share, by Product Segment, 2014–2030 

Figure 155: APEJ Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by CT Injectors Product Segment, 2014–2030

Figure 156: APEJ Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by CT Injectors Product Segment, 2014–2030

Figure 157: APEJ Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by MRI Injectors Product Segment, 2014–2030

Figure 158: APEJ Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by MRI Injectors Product Segment, 2014–2030

Figure 159: APEJ Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Cardiology Injectors Product Segment, 2014–2030

Figure 160: APEJ Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Cardiology Injectors Product Segment, 2014–2030

Figure 161: APEJ Contrast Media Injectors Market Attractiveness Analysis, by Product Segment, 2014–2030

Figure 162: APEJ Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Hospitals End User Segment, 2014–2030

Figure 163: APEJ Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Hospitals End User Segment, 2014–2030

Figure 164: APEJ Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by ASCs End User Segment, 2014–2030

Figure 165: APEJ Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by ASCs End User Segment, 2014–2030

Figure 166: APEJ Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Diagnostic Centres End User Segment, 2014–2030

Figure 167: APEJ Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Diagnostic Centres End User Segment, 2014–2030

Figure 168: APEJ Contrast Media Injectors Market Value Share, by End User, 2014–2030 

Figure 169: APEJ Contrast Media Injectors Market Y-o-Y Growth Rate, by End User, 2014–2030

Figure 170: APEJ Contrast Media Injectors Market Attractiveness Analysis, by End User, 2014–2030

Figure 171: Japan Contrast Media Injectors Market Y-o-Y Growth Rate, by Product Segment, 2014–2030

Figure 172: Japan Contrast Media Injectors Market Value Share, by Product Segment, 2014–2030 

Figure 173: Japan Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by CT Injectors Product Segment, 2014–2030

Figure 174: Japan Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by CT Injectors Product Segment, 2014–2030

Figure 175: Japan Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by MRI Injectors Product Segment, 2014–2030

Figure 176: Japan Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by MRI Injectors Product Segment, 2014–2030

Figure 177: Japan Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Cardiology Injectors Product Segment, 2014–2030

Figure 178: Japan Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Cardiology Injectors Product Segment, 2014–2030

Figure 179: Japan Contrast Media Injectors Market Attractiveness Analysis, by Product Segment, 2014–2030

Figure 180: Japan Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Hospitals End User Segment, 2014–2030

Figure 181: Japan Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Hospitals End User Segment, 2014–2030

Figure 182: Japan Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by ASCs End User Segment, 2014–2030

Figure 183: Japan Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by ASCs End User Segment, 2014–2030

Figure 184: Japan Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Diagnostic Centres End User Segment, 2014–2030

Figure 185: Japan Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Diagnostic Centres End User Segment, 2014–2030

Figure 186: Japan Contrast Media Injectors Market Value Share, by End User, 2014–2030 

Figure 187: Japan Contrast Media Injectors Market Y-o-Y Growth Rate, by End User, 2014–2030

Figure 188: Japan Contrast Media Injectors Market Attractiveness Analysis, by End User, 2014–2030

Figure 189: MEA Contrast Media Injectors Market Value Share, by Country, 2014–2030 

Figure 190: MEA Contrast Media Injectors Market   Y-o-Y Growth Rate, by Country, 2014–2030

Figure 191: MEA Contrast Media Injectors Market Value (US$ Mn) & 

Figure 192: MEA Contrast Media Injectors Market Absolute $ Opportunity 

Figure 193: MEA Contrast Media Injectors Market Value (US$ Mn) & 

Figure 194: MEA Contrast Media Injectors Market Absolute $ Opportunity 

Figure 195: MEA Contrast Media Injectors Market Value (US$ Mn) & 

Figure 196: MEA Contrast Media Injectors Market Absolute $ Opportunity 

Figure 197: MEA Contrast Media Injectors Market Attractiveness Analysis, by Country, 2014–2030

Figure 198: MEA Contrast Media Injectors Market Y-o-Y Growth Rate, by Product Segment, 2014–2030

Figure 199: MEA Contrast Media Injectors Market Value Share, by Product Segment, 2014–2030 

Figure 200: MEA Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by CT Injectors Product Segment, 2014–2030

Figure 201: MEA Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by CT Injectors Product Segment, 2014–2030

Figure 202: MEA Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by MRI Injectors Product Segment, 2014–2030

Figure 203: MEA Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by MRI Injectors Product Segment, 2014–2030

Figure 204: MEA Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Cardiology Injectors Product Segment, 2014–2030

Figure 205: MEA Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Cardiology Injectors Product Segment, 2014–2030

Figure 206: MEA Contrast Media Injectors Market Attractiveness Analysis, by Product Segment, 2014–2030

Figure 207: MEA Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Hospitals End User Segment, 2014–2030

Figure 208: MEA Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Hospitals End User Segment, 2014–2030

Figure 209: MEA Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Diagnostic Centres End User Segment, 2014–2030

Figure 210: MEA Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Diagnostic Centres End User Segment, 2014–2030

Figure 211: MEA Contrast Media Injectors Market Value Share, by End User, 2014–2030 

Figure 212: MEA Contrast Media Injectors Market Y-o-Y Growth Rate, by End User, 2014–2030

Figure 213: MEA Contrast Media Injectors Market Attractiveness Analysis, by End User, 2014–2030

Figure 214: Global Contrast Media Injectors Company Market Share Analysis, 2021

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Needle-Free Vaccine Injectors Market

Published : August 2021

Healthcare

Magnetic Resonance Imaging (MRI) Contrast Agents Market

Published : January 2022

Healthcare

MRI Pulse Oximeters Market

Published : February 2022

Healthcare

MRI Guided Neurosurgical Ablation Market

Published : December 2021

Google translate

Contrast Media Injectors Market